![glp-1 agonist and dpp-4 inhibitor Clinical Use of Inhibitors dpp-4_inhibitors [TUSOM | Pharmwiki]](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ca5/6593043/0d717b9df49a/fendo-10-00389-g0003.jpg)
glp-1 agonist and dpp-4 inhibitor Clinical Use of Inhibitors dpp-4_inhibitors [TUSOM | Pharmwiki]
Description
A., Bateman, B
![glp-1 agonist and dpp-4 inhibitor Clinical Use of Inhibitors dpp-4_inhibitors [TUSOM | Pharmwiki]](https://tmedweb.tulane.edu/pharmwiki/lib/exe/fetch.php/dpp4.png?w=600&tok=f9724b)
doi: 10.2337/db11-0979 36 SarsonDLWoodSMKansalPCBloomSR
![glp-1 agonist and dpp-4 inhibitor Clinical Use of Inhibitors dpp-4_inhibitors [TUSOM | Pharmwiki]](https://www.thelancet.com/cms/10.1016/S0140-6736(06)69705-5/asset/079012c9-a24f-4391-ba39-2f5d03668f6f/main.assets/gr1_lrg.jpg)
Within this framework, incretins particularly glucagon-like peptide-1 (GLP-1) have emerged as key immunometabolic regulators rather than merely glucose-lowering hormones
![glp-1 agonist and dpp-4 inhibitor Clinical Use of Inhibitors dpp-4_inhibitors [TUSOM | Pharmwiki]](https://ars.els-cdn.com/content/image/1-s2.0-S0003426613000188-gr1.jpg)
Efficacy and safety of short- and long-acting GLP-1 receptor agonists on a background of basal insulin in type 2 diabetes: a meta-analysis
![glp-1 agonist and dpp-4 inhibitor Clinical Use of Inhibitors dpp-4_inhibitors [TUSOM | Pharmwiki]](https://www.researchgate.net/publication/49602453/figure/tbl1/AS:669971042562051@1536744952276/Comparison-of-GLP-1-receptor-agonists-and-DPP-4-inhibitors.png)
Hsia DS, Grove O, Cefalu WT
![glp-1 agonist and dpp-4 inhibitor Clinical Use of Inhibitors dpp-4_inhibitors [TUSOM | Pharmwiki]](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs13098-024-01412-x/MediaObjects/13098_2024_1412_Fig2_HTML.png)
MMW Fortschr Med
![glp-1 agonist and dpp-4 inhibitor Clinical Use of Inhibitors dpp-4_inhibitors [TUSOM | Pharmwiki]](https://www.researchgate.net/publication/260680847/figure/fig3/AS:513088665001985@1499341278619/Fig-3-Mechanism-of-action-for-GIP-GLP-1-analogues-and-DPP4-inhibitors-in-controlling.png)
